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Aim: The purpose of this systematic review was to critically examine the literature about the 
effectiveness of rooming-in compared to traditional care settings such as the Neonatal Intensive 
Care Unit (NICU) for newborns with Neonatal Abstinence Syndrome (NAS).  
Background: NAS is a multi-system disorder observed in newborns experiencing withdrawal 
following in-utero opioid exposure. Rooming-in may be beneficial to newborns with NAS as 
outcomes may reduce the need for pharmacologic treatment, the duration of pharmacologic 
treatment, and shorten length of stay (LOS). Although the studies support rooming-in, 
information in this area of research is limited. Based on the little evidence known, rooming-in 
may provide beneficial outcomes for newborns with NAS symptoms. Therefore examining the 
outcomes of NAS and rooming-in may be insightful to the contribution of research in this area of 
NAS.  
Method: A systematic search exploring the effects of rooming-in and NAS in newborns was 
conducted using the following electronic databases: Pubmed, Proquest, PsychoInfo, OVID 
Joanna Briggs Institute of systematic reviews, CINAHL, Nursing and Allied Health, Evidence-
Based Medicine, Web of Science, Cochrane Database of Systematic Review, DARE and 
Medline (EMBASE). Studies were eligible for inclusion in the review if they fulfilled the 
following criteria: (1) reported outcome data for newborns with NAS and rooming-in care, (2) 
primary studies, (3) quantitative studies with a comparison group, (4) peer-reviewed, and (5) 
were published in English. Selected studies were assessed by two appraisers using the JBI 
Standardized critical appraisal checklist for cohort studies.   
 
iv 
Findings: The search identified two hundred sixteen (n = 216 studies). An additional two studies 
were retrieved through a forward citation search. Following removal of studies that did not meet 
the inclusion criteria, six studies remained for the systematic review. The results from this review 
suggest that rooming-in has the potential to improve NAS outcomes including: a decreased need 
for pharmacologic treatment, a shorter duration of pharmacologic treatment, a reduction in 
hospital stay, and healthcare cost savings. These findings support the need for rooming-in to care 
for newborn with NAS symptoms.  
Conclusion: The findings from this systematic review suggest that rooming-in for newborns with 
NAS was effective in reducing the duration of pharmacologic treatment, need for pharmacologic 
treatment, and length of hospital stay compared to traditional care settings. Rooming-in should 
be explored as a care model for select newborns however further investigation is required with 
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Rooming-in and Neonatal Abstinence Syndrome 
A Systematic Review 
The rise in opioid substance use has led to a high prevalence of Neonatal Abstinence 
Syndrome (NAS) in Canada, United States, Europe and Australia (Davies, Gilbert, Johnson, 
Petersen, Nazareth, O’Donnell, Guttmann, & Gonzalex-Izquierdo, 2016) thereby identifying a 
global concern. Newborns of mothers who utilize opioid substances may develop NAS and 
typically require prolonged care in the Neonatal Intensive Care Unit (NICU) (Saiki, Lee, 
Hannam & Greenough, 2009). While NICU care is common, emerging evidence supporting 
rooming-in has been noted as an effective care approach to caring for this population of 
newborns resulting in shorter hospital admissions, reduced duration of pharmacologic treatment 
(Hunseler, Bruckle, Roth & Kribs, 2013), a decreased need for pharmacologic treatment and less 
interference between maternal-newborn bonding (Saiki et al., 2009).  
NAS is a multi-system disorder observed in newborns experiencing withdrawal following 
in-utero opioid exposure (Dow, Ordean, Murphy-Oikonen, Pereira, Koren, Roukema, & Turner, 
2012; McQueen & Murphy-Oikonen, 2016). Exposure to opiates may result in poor neonatal 
outcomes such as low birth weight (Dow et al., 2012), preterm birth, congenital malformations, 
small for gestational age, and stillbirths (Norgaard, Neilsson, & Heide-Jorgensen, 2015). 
NAS is characterized by dysregulation in the neurologic, autonomic, and gastrointestinal 
systems (Patrick, Kaplan, Passarella, Davis, & Lorch, 2014). Neurologic irritability includes 
tremors, irritability, high-pitched crying, reduced quality and length of sleep, increased muscle 
tone, seizures, hyperactive deep tendon reflexes and exaggerated moro reflex (Hudak & Tan, 
2012). Autonomic dysregulation includes sweating, frequent yawning, sneezing, and increased 
respiration (Jansson, Velez, & Harlow, 2009).  Gastrointestinal dysfunction includes difficulties 
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in feeding, loose stools, excessive sucking, regurgitation or projectile vomiting (McQueen, 
Murphy-Oikonen & Desaulniers, 2015).  
The onset of NAS is likely observed within 24-72 hours (Hudak & Tan, 2012). However, 
a recent study reported the onset of NAS symptoms might appear as early as 8.3 hours after birth 
(McQueen, Murphy-Oikonen, & Desaulniers, 2015). Delayed onset of NAS may occur later 
depending on the half-life of the opioid substance (Kocherlakota, 2014). The symptoms of NAS 
varies with the opioid, maternal drug history, maternal metabolism, net transfer of the substance 
across the placenta, placental metabolism, and newborn metabolism and excretion (Hudak & 
Tan, 2012).  
Typically newborns with NAS are cared for in the NICU where they are monitored by 
nursing staff and often placed on a treatment protocol which may include pharmacologic 
treatment (Brown, Hayes, & LaBrie, 2011). The NICU is often noisy, bright, and isolating which 
may be counterproductive to caring for this population of newborns, therefore rooming-in has 
been encouraged (McKnight, Coo, Davies, Holmes, Newman, Newton, & Dow, 2015) in some 
healthcare institutions. Caring for newborns in NICU may be necessary for newborns with severe 
NAS symptoms (Hunseler et al., 2013) but presents barriers for mothers to bond with their 
newborns as separation typically occurs (Abrahams, MackKay-Dunn, Nevmerjitskaia, MacRae, 
Payne, & Hodgson, 2010). Maternal-newborn separation has led to concerns regarding bonding 
and long-term neurodevelopmental impacts on the newborn (Haabrekke, Slinning, Walhovd, 
Wentzel-Larsen, & Moe, 2014; Kocherlakota, 2014). Other barriers such as weaning can prolong 
pharmacologic treatment, hospital admissions and contribute to greater healthcare costs 
(Boucher, 2017; Patrick, Kaplan Passarella, Davis, & Lorch, 2014). As evidence suggests, the 
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median length of stay (LOS) for newborns being treated for NAS can range from 8 to 28 days 
and costs a median of $26 438 to $155 386 USD (Patrick et al., 2014).  
Rooming-in is an alternative care approach whereby newborn and mother remain 
together in one room with support and observation from the healthcare team (Abrahams, Kelly, 
Payne, Thiessen, Mackintosh, & Janssen, 2007; Grossman, Berkwitt, Osborn, Shapiro,  Bizzaro, 
Xu, & Esserman, 2017; Holmes, Atwood, Whalen, Beliveau, Jarvis, Matulis, & Ralston, 2016; 
Hunseler et al., 2013; McKnight et al., 2015; Saiki et al., 2009). One of the benefits of rooming-
in is that it may facilitate breastfeeding (McKnight et al., 2015). Evidence in the literature also 
suggests higher instances of breastfeeding in rooming-in have been associated with delayed onset 
of NAS, reduced severity, and decreased need for pharmacologic treatment (Abdel-Latif, Pinner, 
Clews, Cooke, Lui, & Oei, 2006; Saiki et al., 2009).  Another potential benefit of rooming-in is 
the decreased utilization of healthcare resources (McKnight et al., 2015).   
While the NICU is a traditional care setting for newborns with NAS, there is evidence 
that treatment in the NICU may prolong the need and duration of pharmacologic treatment and 
lengthen hospital admissions compared to rooming-in (Newman, Davies, Dow, Holmes, 
MacDonald, McKnight, & Newton, 2015; Abrahams et al., 2007; Boucher, 2017). Thus, 
evaluating the effects of rooming-in over traditional NAS care settings for the treatment of NAS 
is needed. Currently, there are no systematic reviews that analyze the effects of rooming-in for 
NAS. Thus, the purpose of this systematic review was to critically examine the literature about 
the effectiveness of rooming-in compared to traditional care settings such as the Neonatal 







The electronic databases Pubmed, Proquest, PsychoInfo, OVID Joanna Briggs Institute of 
systematic reviews, CINAHL, Nursing and Allied Health, Evidence-Based Medicine, Web of 
Science, Cochrane Database of Systematic Review, DARE and Medline (EMBASE)were 
searched between December 2017 and January 2018. Subject terms used included "neonatal 
abstinence syndrome" (MeSH) or Neonate* AND Opiate* and one of the following additional 
terms, “rooming-in” or “rooming in”, OR “non-separation” OR “non separation”, OR “maternal 
presence”. To ensure relevant studies had not been missed, the reference lists of included studies 
were reviewed for additional studies meeting the inclusion criteria.  
Study Selection 
The review followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) statement (Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009). 
Studies examining rooming-in for this review met the following inclusion criteria: 1) reported 
outcome data for newborns with NAS and rooming-in care, 2) primary studies, 3) quantitative 
studies with a comparison group, 4) peer-reviewed, and 5) were published in English. For this 
review, NAS was defined as a postnatal withdrawal syndrome in newborns that were exposed to 
opioids in utero (McQueen & Murphy-Oikonen, 2016).  Thus, NAS in newborns exclusively 
from substances other than opioids were excluded. Studies exclusion criteria included 1) 
newborns re-admitted to the hospital for NAS post-discharge and 2) qualitative or quantitative 
studies of maternal experience, 3) not a primary study or no comparison group, 4) outcomes 




Student (TJB) entered all studies from the search criteria into the Zotero Reference 
Manager. Duplicates were removed, and remaining studies were screened for inclusion based on 
the title and abstract and full-text by the student (TJB) (see Appendix A – Diagram 1. PRISMA 
Flow Diagram). Studies that did not meet the inclusion criteria were eliminated for further 
review.   Twenty full-text studies were assessed for eligibility based on the inclusion criteria by 
the student (TJB). Supervisor 1 (JMO) independently screened all the potential studies for 
inclusion based on the study title, abstract, and if necessary, the full text. Student (TJB) and 
supervisor 1 (JMO) collectively discussed the remaining studies (n = 20) and reviewed them 
together. Fourteen additional studies were removed as they did not meet the inclusion criteria. 
Both came to a consensus that six studies (n = 6) were eligible for this review.  
Data Extraction 
Data from full-text studies were extracted by student (TJB). A data extraction template 
was developed for the systematic review to capture all relevant details (see Appendix B, Table 1-
Characteristics of Included Studies). The template included the authors' names, date of 
publication, research design and setting, purpose of study, population and sample size and 
quality appraisal risk of bias. Supervisor 1 (JMO) also independently extracted data onto a 
template. The extracted data were then compared and differences were discussed, referring back 
to the study until agreement was obtained. A secondary table was developed to capture the 
quantitative outcomes of rooming-in and NAS (see Appendix C, Table 2- Outcomes of 
Rooming-in). Data from the studies were also independently extracted by student (TJB) and 
supervisor 2 (KM) and placed into a data extraction template. The template captures the authors’ 
names, date of publication as well as the following outcomes of rooming-in and NAS: 
pharmacologic treatment, duration of pharmacologic treatment, length of stay, breastfeeding, 
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healthcare costs, and discharge to maternal custody. The extracted data were then compared and 
differences were discussed in collaboration with supervisor 1 (JMO). All parties referred back to 
the studies until an agreement was obtained. The data on rooming-in and Neonatal Abstinence 
Syndrome was synthesized narratively as meta-analysis was not possible due to the heterogeneity 
of the included study samples and outcomes evaluated.  
Assessment of Methodological Quality 
 The studies selected for the systematic review was assessed for methodological quality 
using the Joanna Briggs Institute (JBI) Standardized Critical Appraisal Checklist for Cohort 
Studies (Joanna Briggs Institute, 2014) (see Appendix D-JBI Critical Appraisal Checklist for 
Cohort Studies). The selected studies for inclusion were independently reviewed by student 
(TJB) and supervisor 2 (KM). Studies were evaluated based on low, moderate or high risk of 
bias. Ratings to determine level of risk were based on: sample selection bias, confounding 
factors, strategies to deal with confounding factors, validity and reliability of NAS outcomes, and 
follow-up. Any discrepancies between raters’ scores were discussed and resolved with supervisor 
1 (JMO) until a consensus was reached. Based on the evaluation of critical appraisal, none of the 
studies were eliminated from this review.  
Results 
The search identified two hundred sixteen studies (n = 216). An additional two studies 
were retrieved through a forward citation search. Following removal of duplicates, a total of one 
hundred eighteen studies (n = 118) studies remained for review. An initial title and abstract 
search eliminated ninety eight (n = 98) studies with twenty (n = 20) studies remaining for full-
text search resulting in six (n = 6) studies that met the inclusion criteria for the systematic 
review. Fourteen full-text studies were eliminated from inclusion based on the following: 1) not 
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a primary study or no comparison group (n = 6); 2) outcomes were based on pharmacologic 
treatment interventions for newborns (n=4); and 3) no outcome data for rooming-in (n=4) (see 
Appendix A – Diagram 1. PRISMA Flow Diagram). 
Rooming-in and NAS Outcomes 
Study Characteristics 
The characteristics of the six included studies are provided in Appendix C Table 1. Of the 
six studies, four explored the effects of rooming-in (Abrahams et al.,2007; Hunseler et al.,2013; 
McKnight et al. 2016; Saiki et al.,2009) and two studies were quality improvement initiatives for 
NAS (Grossman et al., 2017; Holmes et al.,2016), which included rooming-in. Studies were 
conducted in Canada (n = 2), United Kingdom (n =  1), Germany (n = 1), and in the United 
States (n = 2) between the years of 2001-2016. The selected studies were comprised of 
retrospective cohort designs (n = 3) and cohort studies (n = 3). Sample size for studies evaluating 
newborns with NAS ranged from 44 to 287 and the single study with a sample of women using 
heroin or methadone had a sample size of one hundred six (n = 106). Studies explored various 
NAS outcomes associated with rooming-in including 1) pharmacologic treatment, 2) duration of 
pharmacologic treatment, 3) LOS in hospital, 4) healthcare cost, 5) breastfeeding and 6) 
discharge to maternal custody.  
Methodological Quality 
Among the studies, three were identified as a low risk of bias (Abrahams et al., 2007; 
McKnight et al., 2015; Saiki et al., 2009) and three studies were identified as a moderate risk of 
bias (Grossman et al., 2017; Holmes et al., 2016; Hunseler et al., 2013). Selection bias for 
rooming-in was present in two studies (Abrahams et al., 2007; Hunseler et al., 2013) as between-
group differences were identified. For example in the study by Hunseler et al., (2013) 
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participants self-selected traditional care or rooming-in. It is unclear if those who selected the 
rooming-in cohort were more stable or more motivated than the traditional care cohort (Hunseler 
et al., 2013). Two studies did not have selection bias as the intervention and control groups had 
similar maternal and newborn characteristics such as maternal age, substance use, gestational 
age, and birth weight and between-group differences were not statistically significant (McKnight 
et al., 2015; Saiki et al., 2009). It was unclear if there was selection bias present in two studies 
(Grossman et al., 2017; Holmes et al., 2016) as both studies examined quality improvement and 
did not have a clear rooming-in cohort (Grossman et al., 2017; Holmes et al., 2016). 
Potential confounding factors such as training for staff, the encouragement of 
breastfeeding, cuddling and swaddling were present in a few of the studies (Abrahams et al., 
2007; Hunseler et al., 2013; McKnight et al., 2015 & Saiki et al., 2009). Some of these 
confounding variables were adjusted and subsequently accounted for in the final analysis 
(Grossman et al., 2017; Holmes et al., 2016). All studies used scoring tools as a guide to treat 
symptoms of NAS (Abrahams et al., 2007; Grossman et al., 2017; Holmes et al., 2016; Hunseler 
et al., 2013; McKnight et al., 2015 & Saiki et al., 2009). However, the specific scoring tools, who 
administered the assessments and their protocols varied; thus, making between-study 
comparisons difficult. Lastly, it is difficult to ascertain whether any of the studies lost any of 
their participants during the course of examination as this is not addressed in the final outcome of 
the studies.  
Rooming-in and NAS Outcome: Pharmacologic Treatment 
All six studies examined pharmacologic treatment as an outcome of rooming-in. All of 
studies found a reduced need for pharmacologic treatment among newborns rooming-in with 
their mothers. Four studies reported a statistically significant difference between groups 
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(Abrahams et al., 2007; Grossman et al., 2017; McKnight et al., 2016; Saiki et al.,2009), while 
one study did not report a p value (Holmes et al., 2016) and one study reported no statistical 
significance (Hunseler et al.,2013). The percentage of newborns receiving pharmacologic 
treatment varied among the groups. Among those receiving rooming-in the percentage requiring 
pharmacologic treatment varied from 11% (Saiki et al., 2009) to 79.2% (Hunseler et al., 2013). 
Rates of pharmacologic treatment among controlled group participants were much higher, 
ranging from 45% (Saiki et al., 2009) to 98% (Grossman et al., 2017).  
Rooming-in and NAS Outcome: Duration of Pharmacologic Treatment 
 Among the six studies included in this review, four of the studies measured the duration 
of pharmacologic treatment (Abrahams et al., 2007; Hunseler et al., 2013; McKnight et al., 2015; 
Saiki et al, 2009). Two of the studies evaluated the mean duration of treatment, which ranged 
from 5.9 days to 7.3 days for the rooming-in cohorts and 12.7 days to 18.6 days for the 
traditional care setting cohorts (Abrahams et al., 2007; Saiki et al., 2009). Two studies evaluated 
the (median) and (maximum – minimum values, Interquartile Range (IQR)) which ranged from 
24.0 days to 27 days for rooming-in cohorts compared to traditional care setting cohorts which 
ranged from 29.5-32.5 days  (Hunseler et al., 2013; McKnight et al., 2015). Abrahams et al. 
(2007) was the only study to find statistically significant results concerning the duration of 
pharmacologic treatment (p=0.003) and concluded that the rooming-in cohort had shorter 
durations of pharmacologic treatment.  
Rooming-in and NAS Outcome: Length of Stay 
All of the studies found a decrease in the average LOS for newborns with NAS that 
roomed-in with their mothers when compared to traditional care setting. Average length of stay 
for newborns rooming-in ranged from 5 days (McKnight et al., 2015) to 15.9 days (Saiki et al., 
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2009). Among controls, average length of stay was higher, ranging from 19.8 days (Saiki et al., 
2009) – 41.5 days (Hunseler et al., 2013). While all six studies found shorter LOS among those 
rooming-in, only four studies found a statistically significant reduction in LOS (Abrahams et al., 
2007; Grossman et al., 2017; McKnight et al., 2015; Saiki et al., 2009). One study did not report 
a p value (Holmes et al., 2016) and another found no significant difference (Hunseler et al., 
2013).  
Rooming-in and NAS Outcome: Healthcare Costs 
Healthcare costs were evaluated among three out of six included studies. All three studies 
found considerable financial savings for newborns who roomed-in with their mothers (Grossman 
et al., 2017; Holmes et al., 2016; Hunseler et al., 2013). The evaluation criteria for healthcare 
costs was diverse as each study was conducted in a different country with varying healthcare 
systems and different currency (Grossman et al., 2017; Holmes et al., 2016; Hunseler et al., 
2013). Hunseler et al. (2013) noted a mean cost of 9547 € amongst the rooming-in cohort in 
comparison to the traditional care setting cohorts 14 486 € per admission (p<0.014) representing 
a cost savings of 66 %. Similarly, in a US study, Holmes et al. (2016) found a statistically 
significant decrease in healthcare costs associated with rooming-in for NAS. The average costs 
of hospitalization for a newborn with NAS decreased from the baseline year cohort ($11,000 
USD) to the second year intervention cohort ($5300 USD) (p<0.01) for a cost saving of 48%. 
Finally, in another US based study, Grossman et al. (2017) identified significant cost savings and 
noted the average cost of hospitalization for the rooming-in cohort was $10,289 vs. $44,824 for 





Rooming-in and NAS Outcome: Breastfeeding  
Breastfeeding was evaluated in five of the six studies. While each study reported a higher 
number of breastfeeding mothers in the rooming-in cohorts compared to traditional care settings, 
only Grossman et al., 2017 found this to be statistically significant (p=.01). Rates of 
breastfeeding within the rooming-in cohort were (n=20) or 44% of the sample size while the 
rates of breastfeeding in the traditional care cohort were (n=11) or 20% of the sample size. Two 
studies reported additional findings that among newborns who were breastfed, there was less of a 
need for pharmacologic treatment (Holmes et al., 2016; McKnight et al., 2015). McKnight et al. 
(2015) evaluated any form of breastfeeding and reported that newborns in the NICU cohort (n = 
9, 75%) that were formula fed, required more pharmacologic treatment than the breastfed 
newborns in the rooming-in cohort (n=1) or 16.7% (p=0.04). Similarly, formula fed newborns 
remained in hospital an average of 19.5 days compared to newborns that were breastfed and 
remained an average of 4.5 days in hospital (McKnight et al., 2015).  
Rooming-in and NAS Outcome: Discharged to Maternal Custody 
Among the 4 studies evaluating discharge to maternal custody, mothers who roomed in 
with their newborns had higher rates of custody over their newborn at discharge (Abrahams et 
al., 2007; Holmes et al., 2016; Hunseler et al., 2013; Saiki et al.,2009). In particular, the study by 
Abrahams et al. (2007), the relative risk (RR) of newborns discharged home was 2.23 (95% CI 
1.43 to 3.98); concluding that mothers who roomed in at British Columbia Women’s Hospital 
(BCWH) with their newborns were 2.2 times more likely to be discharged home. Likewise, when 
compared with the Surrey Cohort control group, the RR was 1.52 (95% CI 1.15 to 2.53) resulting 
in a 1.5 times greater likelihood that mothers who roomed in with their newborns had custody 
upon discharge from the hospital. While the other three studies had higher rates of discharge 
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home, the differences between rooming-in and controls groups were not statistically significant 
(Holmes et al., 2016; Hunseler et al., 2013; Saiki et al., 2009). 
Discussion 
This is the first systematic review to assess the effects of rooming-in for newborns with 
NAS. The most frequently evaluated outcomes of included studies were the average length of 
stay in hospital, the need for pharmacologic intervention and duration of treatment. Overall, all 
studies consistently identified that the average LOS was reduced when newborns roomed-in with 
their mothers. Similarly, newborns that roomed-in required pharmacologic treatment less 
frequently and had shorter duration of treatment in comparison to traditional care setting cohorts. 
While the trend was positive for rooming in, not all studies had statistically significant findings. 
This review also found a positive association between rooming-in and lower health care costs, 
increased rates of breastfeeding and discharge home with mothers. However, these outcomes 
were evaluated less frequently within the studies.  
Reducing length of stay is important as in 2004, the average length of stay for newborns 
with NAS in NICU was 13 days. Subsequently, this increased to 19 days by 2013. (Tolia, 
Patrick, Bennett, Murphy, Sousa, & Smith, 2015). Given the long length of hospital stays for 
newborns with NAS receiving traditional care, rooming in may be a viable intervention to 
decrease length of stay.  
Prolonged admissions in NICU can create difficulties for maternal-newborn bonding 
(Boucher, 2017; Newman et al., 2015; Saiki et al., 2009), given that maternal and newborn 
separation precludes consistent care from the mother. Newborns that remain with their mothers 
benefit from one on one care, frequent healthcare supervision, and remain in a more natural 
environment than the NICU (Saiki et al., 2009).  
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Another concern for mothers attending the NICU to care for their newborns is the 
existence of stigma from healthcare providers. Stigma may have a profound impact on the 
mother’s ability to be present at the hospital and bond with their newborn (Murphy-Oikonen, 
Montelpare, Southon, Bertoldo, Persichino, 2010) as it may increase feelings of guilt and shame 
related to their use of opioids. Mothers with a substance use history may have more difficulty 
interacting with nurses in traditional care settings as evidence suggests that some nurses are 
judgemental towards women who have used opiates during pregnancy (Cleveland & Bonugli, 
2014; Murphy-Oikonen et al., 2010). Mothers’ experiences with stigma from healthcare 
providers may impact lower attendance while the newborn is in hospital, thereby further limiting 
opportunities for bonding (Johnson, 2017).    
Reducing the need for pharmacologic treatment is another important outcome that 
warrants attention. Approximately 60-80% of newborns with NAS require pharmacologic 
treatment (Tolia et al., 2015). Our systematic review found that newborns that roomed-in with 
mothers received less pharmacologic treatment than newborns that remained in traditional care 
settings (Abrahams et al., 2007; Grossman et al., 2017; Holmes et al., 2016; Hunseler et al., 
2013; McKnight et al., 2015 & Saiki et al., 2009). A decreased need for pharmacologic treatment 
is important given that research is limited on the neurodevelopment of newborns and postnatal 
(opioids) pharmacologic treatment (Devlin, Lau & Radmacher, 2017). Thus, utilizing rooming-in 
reduces the need for pharmacologic treatment in newborns with NAS, and may reduce the risk of 
possible long-term effects.  
Pharmacologic treatment may prolong hospital admission and healthcare costs (Holmes 
et al., 2016).  The systematic review findings suggest that rooming in is associated with 
decreased healthcare costs for newborns with NAS (Holmes et al., 2016; Hunseler et al., 2013; 
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Saiki et al., 2009). In the United States, the cost for a newborn being pharmacologically treated 
can be anywhere from 2 to 12 weeks and reported costs of approximately $90 000 per admission 
(Holmes et al., 2016). Correspondingly, the mean cost in 2009 to treat a newborn with NAS 
exceeded $53 000 (Patrick, Schumacher, Benneyworth, Krans, McAllister, & Davis, 2012). 
Although rooming-in is associated with cost-savings, the lack of clarity on how healthcare costs 
are evaluated in each of the included studies requires caution in the interpretation of this 
outcome. While the overall cost of healthcare savings may be a positive outcome, Holmes et al. 
(2016) argue that a reduction in hospital revenue in fee-for-service environments may lead to 
closure of some necessary services within the hospital. Similarly, while there is evidence of in-
patient cost savings, there is uncertainty regarding the cost to primary care providers in the 
community.   
Our findings regarding increased rates of breastfeeding are consistent with other studies 
that identified rooming-in may enhance maternal ability to initiate breastfeeding. Additionally, 
breastfeeding can provide emotional stability to the newborn and increase mother’s confidence in 
caring for her newborn (Shrivastava, Shrivastava, & Ramasamy, 2013). There are also many 
associated benefits to breastfeeding newborns with NAS such as improved health, alleviating 
severity of NAS symptoms, optimal nutrition, mother-newborn bonding and the opportunity for 
mothers to enhance their parenting skills by reducing separation (MacVicar, Humphrey, & 
Forbes-McKay, 2017; Shrivastava et al., 2013; Welle-Strand, Skurtveit, Jansson, Bakstad, 
Bjarko, & Ravndal, 2013). Breastfeeding should be recommended as a non-pharmacologic 
intervention among mothers that are stabilized on Opioid Replacement Therapy (ORT) (Abdel-
Latif, Pinner, Clews, Cooke, Lui & Oei. 2006; O’Connor, Collett, Alto, & O’Brien, 2013) as 
there are positive outcomes for newborns with NAS. In particular, the literature on breastfeeding 
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and NAS suggests that mothers who breastfeed their newborns are more likely to have a delayed 
or reduced onset of NAS (Saiki et al., 2009), reduce severity (Saiki et al., 2009), reduced LOS, 
and reduced need for pharmacologic treatment (Abdel-Latif et al., 2006; O’Connor et al., 2013; 
Saiki et al., 2009; Welle-Strand et al., 2013). As such, improving breastfeeding rates with 
rooming-in could also assist in mitigating NAS symptoms. However, historically breastfeeding 
among this population of mothers and newborns was not encouraged (O’Connor et al., 2013). As 
such, mothers of newborns with NAS have been less likely to initiate or sustain breastfeeding 
(Holmes, Schmidlin, & Kurzum, 2017).  
Newborns that are exposed to substances in utero are at greater risk for involvement with 
child protection agencies, with North American studies finding that 1 in 3 children end up in out-
of-home care (O’Donnell, Nassar, Leonard, Hagan, Matthews, Patterson, & Stanley, 2009).  
Among the studies that evaluated discharge to maternal custody (Abrahams et al., 2007; 
Grossman et al., 2017) rooming in was associated with an increased number of newborns 
discharged to mother’s custody when compared to newborns receiving traditional care although 
this was not statistically significant. There are a number of potential reasons that newborns who 
roomed-in with their mothers had higher rates of returning home with their primary caregiver. 
According to Abrahams et al. (2007) the rooming-in cohorts had increased access to resources 
pre and postnatal including access to housing which may also increase the success rates of 
newborns being discharged to maternal care. In addition, mothers who roomed in with their 
newborns presumably received increased supervision and supports from healthcare staff. Despite 
this positive outcome, it is unclear if newborns that roomed in with their mothers represented a 
more socially stable cohort, thus resulting in the increased discharge to maternal care. The 
participants in most of the studies were selected by the researcher (Abrahams et al., 2007; 
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Grossman et al., 2017; Holmes et al., 2016; Mcknight et al., Saiki et al., 2009) with the exception 
of Hunseler et al. (2013) whereby participants had the opportunity to choose rooming in over 
traditional care. Thus, given the inconsistency in the inclusion criteria and support services 
rendered for the rooming-in cohorts, caution is required in the interpretation of this outcome. 
Hidayati (2017) conducted a study on effects of bonding and concluded that hospitals that 
promoted bonding with the guidance and support from healthcare professionals instilled 
confidence within parents to care for their newborns after discharge from hospital.   Increasing 
opportunities for mother and newborn to bond through rooming-in may increase the likelihood of 
maternal presence and in turn, increase the success of newborns remaining in maternal custody 
upon discharge (Newman et al., 2015).  Rooming in also provides an opportunity for healthcare 
professionals to observe mother-newborn interactions which may also address or alleviate any 
child protection concerns prior to discharge (Abrahams et al., 2010; Cleveland et al., 2014).  The 
safety of newborns must be carefully assessed prior to implementation of rooming in (O'Connor, 
Vietze, Sherrod, Sandler, & Altemeier III, 1980) and of subsequent discharge to the maternal 
care provider given that NAS has been associated with social instability in the home (O’Donnell 
et al., 2009).  
Overall, the findings from this review suggest that rooming-in was associated with 
improved outcomes for newborns with NAS. However, as rooming-in varied between studies, it 
is unclear what the effective mechanism of rooming-in entails.  For example, among the included 
studies rooming-in may have included psycho-education, breastfeeding support, specialized 
training of staff, cuddling, swaddling, and increased use of staff and resources. More research 





While the studies offer a variety of strengths pertaining to the effectiveness of rooming-in 
for newborns with NAS, some limitations were observed during this systematic review. The 
majority of included studies were retrospective, before and after studies, with small sample sizes, 
which limit the ability to determine causal relationships. Additionally, all of the studies used 
diverse scoring tools to assess and treat symptoms of NAS (Abrahams et al., 2007; Grossman et 
al., 2017; Holmes et al., 2016; Hunseler et al., 2013; McKnight et al., 2015 & Saiki et al., 2009). 
However, scoring tools ranged from the original Finnegan’s scoring tool (Grossman et al., 2017; 
Hunseler et al., 2013) to a modified version of the Finnegan’s scoring tool (Abrahams et al., 
2007; Holmes et al., 2016; McKnight et al., 2015) to the River Scoring  system (Saiki et al., 
2009). Modified versions of the Finnegan did not include the number of items or specifics of 
how the tool was modified thereby putting the studies at-risk for measurement bias. Moreover, 
many studies did not provide detail whether the healthcare professionals who administered the 
assessment had adequate training or if scoring times were consistent among the samples.   
Another consideration for bias could be the times of when scoring occurred. For instance, in 
some studies newborns were scored after infant-feeding compared to newborns that may have 
been hungry or tired.  In addition to the diversity of scoring, there were additional variations 
between studies in regards to pharmacologic and non-pharmacologic treatment. Some studies 
imposed pharmacologic interventions after two scores of 8 or greater while others studies 
intervened at three consecutive scores of 8 or greater, therefore, implementing pharmacologic 





Implications for Practice 
 The results of this systematic review suggest that rooming-in should be considered a 
viable non-pharmacologic intervention for newborns with NAS. Rooming-in between mother 
and newborn should be encouraged when feasible and symptoms can be treated outside of the 
NICU. However, it is important to note that rooming-in may not be suitable for all mothers and 
newborns as some newborns may require additional treatment in the NICU. Therefore healthcare 
professionals should be aware of the potential risks involved and evaluate suitable candidates. 
Hospitals considering rooming-in should develop adequate policies and protocols which can 
decipher when a newborn will benefit by being in the NICU or rooming-in. A current gap 
identified in the literature is the lack of explicit eligibility criteria for rooming-in. As such, the 
findings of this review are limited to a select group. 
Implications for Future Research 
There is a need for future studies to continue to examine the associated benefits of 
rooming in. Consideration should be given to increasing utilizing prospective or randomized 
designs as they may mitigate selection bias. In addition, using a valid and reliable scoring tool 
with consistent scoring protocols and training of staff to administer the scoring tools will aid in 
having a homogenous sample to evaluate the effectiveness of the rooming-in intervention. 
Further exploration is required to assess the association and anticipated outcomes of 
breastfeeding, discharge to maternal custody, and safety of infants with NAS and rooming-in. 
Finally, detailed description of rooming-in interventions is required so that evaluation may be 






 The findings from this systematic review suggest that rooming-in for newborns with NAS 
was effective in reducing the duration of pharmacologic treatment, need for pharmacologic 
treatment, and length of hospital stay compared to traditional care settings. Rooming-in should 
be explored as a care model for select newborns however further investigation is required with 
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Additional records identified 
through forward citation search 







Records identified through database 
searching including: Pubmed, 
Proquest, PsychoInfo, OVID Joanna 
Briggs Institute of systematic reviews, 
CINAHL, Nursing and Allied Health, 
Evidence-Based Medicine, Web of 
Science, Cochrane Database of 
Systematic Review, DARE and 
Medline (EMBASE). 
(n = 216) 
Records after duplicates removed 
(n = 118) 
Title and Abstract 
screened 
(n = 118) 
Records excluded 
(n = 98) 
Primarily re: no 
rooming-in treatment for 
NAS 
Full text studies assessed 
for eligibility  
(n = 20) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 6) 
Full-text studies 
excluded re:  
(n = 6) not a primary 
study or no comparison 
group 




(n = 4) no outcome data 
for rooming in  




Table 1. Characteristics of Included Studies 
 
Author Research Design &  
Setting 
Purpose of Study Population and Sample Details Quality 
Appraisal  










and Surrey Hospital, 
British Columbia, 
Canada  
To evaluate the effect of 
rooming-in (rather than 
standard nursery care) on the 
incidence and severity of 
neonatal abstinence syndrome 
among opioid-exposed 
newborns and on the proportion 
of mothers who retain custody 
of their babies at hospital 
discharge. 
Total sample (n = 106) methadone or 
heroin using women: 
Rooming in cohort BCWH (RI): 
(n=32) methadone or heroin using 
women);  
 
Pre-rooming in cohort BCWH (C1) 
(n=38)  
Observation nursery cohort level II at 






Yale New Haven 
Children’s Hospital, 
United States 
The aim is to reduce the 
average LOS for newborns 
with NAS by 50% 
  
 
Total sample (n=287) newborns with 
symptoms of NAS 
  
Intervention Cohort (I1): (n=188)  
 
Post-implementation Cohort (I2): 
(n=44)  
 






Cohort Study  
 




To examine the impact of a 
rooming-in program for infants 
at risk of neonatal abstinence 
syndrome (NAS) on the need 
for pharmacologic treatment 
and length of hospitalization. 
Total sample (n=163) newborns with 
symptoms of NAS 
  
Intervention year 1 Cohort (I1): 
(n=61)  
 
Intervention year 2 Cohort (I2): 
(n=48)  













To evaluate the treatment of 
neonatal abstinence syndrome, 
the experience with rooming-in 
of opiate-dependent mothers 
and to examine the influence of 
rooming in on short-term 
outcome of infants exposed to 
opiates in utero 
Total sample (n=77) newborns with 
NAS symptoms 
 
Rooming in cohort (RI): (n=24)  
 












To examine the impact of a 
rooming-in program for infants 
at risk of neonatal abstinence 
syndrome on the need for 
pharmacologic treatment and 
length of hospitalization 
Total sample (n=44) newborns with 
symptoms of NAS 
 
Rooming-in cohort (RI): (n=20) 
 











To test the hypothesis that 
caring for infants with neonatal 
abstinence syndrome with their 
mothers on the postnatal ward 
rather than admit them to the 
neonatal unit would reduce 
treatment duration and length 
of stay. 
Total sample (n = 60) newborns with 
symptoms of NAS 
 
Rooming-in cohort (RI): (n=18) 
newborns  
 












RI & RI2 = Rooming-in Cohorts (Intervention group)   RR = Relative Risk   C1 = Not rooming-in Cohort (control group)   
 p = Probability Value of Statistical Significance  

















Length of Stay 





























































































































































































RI & RI2 = Rooming-in Cohorts (Intervention group)   RR = Relative Risk   C1 = Not rooming-in Cohort (control group)   
 P = Probability Value of Statistical Significance  




































































































































JBI Critical Appraisal Checklist for Cohort Studies 
 
 
 
 
